Lubelski Wegiel Bogdanka SA
F:UXX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lubelski Wegiel Bogdanka SA
F:UXX
|
PL |
|
F
|
Fufeng Group Ltd
XMUN:FFO1
|
CN |
|
U
|
United Labels AG
DUS:ULC
|
DE |
|
D
|
DPC Dash Ltd
OTC:DPCDF
|
CN |
|
I
|
Imax Corp
F:IMA
|
CA |
|
I
|
Innate Pharma SA
XBER:IDD
|
FR |
Wall St Price Targets
UXX Price Targets Summary
Lubelski Wegiel Bogdanka SA
According to Wall Street analysts, the average 1-year price target for UXX is 1.6 EUR with a low forecast of 1.585 EUR and a high forecast of 1.648 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UXX's stock price target?
Price Target
1.6
EUR
According to Wall Street analysts, the average 1-year price target for UXX is 1.6 EUR with a low forecast of 1.585 EUR and a high forecast of 1.648 EUR.
What is the Revenue forecast for Lubelski Wegiel Bogdanka SA?
Projected CAGR
-7%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 7 years is -7%.
What is the Operating Income forecast for Lubelski Wegiel Bogdanka SA?
Projected CAGR
-14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 7 years is -14%.
